Skip to main content

Advertisement

Log in

Feasibility of intraoperative radiation therapy for early breast cancer in Japan: a single-center pilot study and literature review

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

Intraoperative radiation therapy (IORT) is under evaluation in breast-conserving surgery because the feasibility of the IORT procedure including transportation of the patient under general anesthesia is not well established. Thus, this prospective single-center study aimed to test the feasibility of IORT at a single dose of 21 Gy in Japanese breast cancer patients.

Methods

The primary endpoint was early toxicity; the secondary endpoint was late toxicity. Patients with histologically or cytologically proven primary early breast cancer were eligible. Inclusion criteria were as follows: (1) T < 2.5 cm; (2) desire for breast-conserving surgery; (3) age >50 years; (4) surgical margin >1 cm; (5) intraoperative pathologically free margins; and (6) sentinel node negative. Exclusion criteria were (1) contraindications to radiation therapy; (2) past radiation therapy for the same breast or chest; (3) extensive intraductal component; and (4) a tumor located in the axillary tail of the breast. All patients gave written informed consent. Partial resection was performed with at least a margin of 1 cm around the tumor. The patient was transported from the surgical suite to the radiation room. Radiation (Clinac® 21EX, Varian Medical Systems, Inc.) at 21 Gy was delivered directly to the mammary gland. Toxicity was evaluated with the Common Terminology Criteria for Adverse Events V4.0.

Results

Five patients were enrolled in this pilot study and received 21 Gy. Follow-up ranged from 7.8 to 11.0 months (median 10.2). Intraoperative transportation to the radiation room during the surgical procedure under general anesthesia was performed safely in all patients. Treatment-related toxicities within 3 months were deep connective tissue fibrosis (grade 1, n = 3) and pain (grade 1, n = 3). There was no case of wound infection, wound dehiscence, or soft tissue necrosis. Overall, there was no severe adverse event.

Conclusions

The procedure was tolerated very well in this first group of Japanese female patients treated with IORT, as was the case with European women. A longer follow-up is needed for the evaluation of any potential late side effects or recurrences. A phase II study is now being conducted for the next group of patients (UMIN000003578).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

ALND:

Axillary lymph node dissection

APBI:

Accelerated partial breast irradiation

ASTRO:

American Society for Therapeutic Radiation Oncology

BCT:

Breast-conserving therapy

DCIS:

Ductal carcinoma in situ

EBRT:

External beam radiation

EIC:

Extensive intraductal component

ELIOT:

Electron intraoperative therapy

ER:

Estrogen receptor

IORT:

Intraoperative radiotherapy

LCIS:

Lobular carcinoma in situ

LVSI:

Lymph-vascular space invasion

PBI:

Partial breast irradiation

PMMA:

Polymethyl methacrylate

RT:

Radiotherapy

SN Bx:

Sentinel lymph node biopsy

TARGIT:

Targeted intraoperative radiotherapy

WBI:

Whole breast external irradiation therapy

References

  1. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.

    Article  PubMed  Google Scholar 

  2. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.

    Article  PubMed  Google Scholar 

  3. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.

    Article  CAS  PubMed  Google Scholar 

  4. Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16.

    Article  CAS  PubMed  Google Scholar 

  5. Njeh CF, Saunders MW, Langton CM. Accelerated partial breast irradiation (APBI): a review of available techniques. Radiat Oncol. 2010;5.

  6. Skandarajah AR, Lynch AC, Mackay JR, Ngan S, Heriot AG. The role of intraoperative radiotherapy in solid tumors. Ann Surg Oncol. 2009;16:735–44.

    Article  CAS  PubMed  Google Scholar 

  7. Veronesi U, Orecchia R, Luini A, Gatti G, Intra M, Zurrida S, et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer. 2001;37:2178–83.

    Article  CAS  PubMed  Google Scholar 

  8. Luini A, Orecchia R, Gatti G, Intra M, Ciocca M, Galimberti V, et al. The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the results. Breast Cancer Res Treat. 2005;93:55–9.

    Article  PubMed  Google Scholar 

  9. Veronesi U, Orecchia R, Luini A, Galimberti V, Gatti G, Intra M, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Ann Surg. 2005;242:101–6.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Intra M, Luini A, Gatti G, Ciocca M, Gentilini O, Viana A, et al. Surgical technique of intraoperative radiation therapy with electrons (ELIOT) in breast cancer: a lesson learned by over 1000 procedures. Surgery. 2006;140:467–71.

    Article  PubMed  Google Scholar 

  11. Veronesi U, Orecchia R, Luini A, Galimberti V, Zurrida S, Intra M, et al. Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat. 2010;124:141–51.

    Article  PubMed  Google Scholar 

  12. Sawaki M, Sato S, Kikumori T, Ishihara S, Aoyama Y, Itoh Y, et al. A phase I study of intraoperative radiotherapy for early breast cancer in Japan. World J Surg. 2009;33:2587–92.

    Article  PubMed  Google Scholar 

  13. Sawaki M, Sato S, Noda S, Idota A, Uchida H, Tsunoda N, et al. Phase I/II study of intraoperative radiotherapy for early breast cancer in Japan. Breast Cancer. 2011. doi:10.1007/s12282-011-0294-1.

  14. Oshima T, Aoyama Y, Shimozato T, Sawaki M, Imai T, Ito Y, et al. An experimental attenuation plate to improve the dose distribution in intraoperative electron beam radiotherapy for breast cancer. Phys Med Biol. 2009;54:3491–500.

    Article  CAS  PubMed  Google Scholar 

  15. Vicini F, Arthur D, Wazer D, Chen P, Mitchell C, Wallace M, et al. Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel guidelines on the use of accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2011;79:977–84.

    Article  PubMed  Google Scholar 

  16. Polgár C, Limbergen EV, Pötter R, Kovács G, Polo A, Lyczek J, et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol. 2010;94:264–73.

    Article  PubMed  Google Scholar 

  17. Orecchia R, Ivaldi GB, Leonardi MC. Integrated breast conservation and intraoperative radiation therapy. Breast. 2009;18(Suppl 3):S98–102.

    Article  PubMed  Google Scholar 

  18. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001;12:997–1003.

    Article  CAS  PubMed  Google Scholar 

  19. Vicini FA, Kestin L, Chen P, Benitez P, Goldstein NS, Martinez A. Limited-field radiation therapy in the management of early-stage breast cancer. JNCI J Nat Cancer Inst. 2003;95:1205–10.

    Article  Google Scholar 

  20. Benitez P, Keisch M, Vicini F, Stolier A, Scroggins T, Walker A, et al. Five-year results: the initial clinical trial of Mammosite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg. 2007;194:456–62.

    Article  PubMed  Google Scholar 

  21. Vicini FA, Baglan KL, Kestin LL, Mitchell C, Chen PY, Frazier RC, et al. Accelerated treatment of breast cancer. J Clin Oncol. 2001;19:1993–2001.

    CAS  PubMed  Google Scholar 

  22. Antonucci JV, Wallace M, Goldstein NS, Kestin L, Chen P, Benitez P, et al. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up. Int J Radiat Oncol Biol Phys. 2009;74:447–52.

    Article  PubMed  Google Scholar 

  23. Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000;18:1668–75.

    CAS  PubMed  Google Scholar 

  24. Fisher ER. Lumpectomy margins and much more. Cancer. 1997;79:1453–8 (discussion 9–60).

    Google Scholar 

  25. Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). J Am Coll Surg. 2009;209:269–77.

    Article  PubMed  Google Scholar 

  26. Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol. 2007;25:3259–65.

    Article  PubMed  Google Scholar 

  27. Antonini N, Jones H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, et al. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol. 2007;82:265–71.

    Article  PubMed  Google Scholar 

  28. Chao KK, Vicini FA, Wallace M, Mitchell C, Chen P, Ghilezan M, et al. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the William Beaumont Hospital experience. Int J Radiat Oncol Biol Phys. 2007;69:32–40.

    Article  PubMed  Google Scholar 

  29. Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74:987–1001.

    Article  PubMed  Google Scholar 

  30. Al-Hallaq HA, Mell LK, Bradley JA, Chen LF, Ali AN, Weichselbaum RR, et al. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer. 2008;113:2408–14.

    Article  PubMed  Google Scholar 

  31. Tendulkar RD, Chellman-Jeffers M, Rybicki LA, Rim A, Kotwal A, Macklis R, et al. Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation. Cancer. 2009;115:1621–30.

    Article  PubMed  Google Scholar 

  32. Houssami N, Ciatto S, Macaskill P, Lord SJ, Warren RM, Dixon JM, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26:3248–58.

    Article  PubMed  Google Scholar 

  33. Turnbull L, Brown S, Harvey I, Olivier C, Drew P, Napp V, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet. 2010;375:563–71.

    Article  PubMed  Google Scholar 

  34. Orecchia R, Leonardo MC. Intraoperative radiation therapy: is it a standard now? Breast. 2011;20(Suppl 3):S111–5.

    Article  PubMed  Google Scholar 

  35. Beal K, McCormick B, Zelefsky M, Borgen P, Fey J, Goldberg J, et al. Single-fraction intraoperative radiotherapy for breast cancer: early cosmetic results. Int J Radiat Oncol Biol Phys. 2007;69:19–24.

    Article  PubMed  Google Scholar 

  36. Chism D, Freedman G, Li T, Anderson P. Re-excision of margins before breast radiation—diagnostic or therapeutic? Int J Radiat Oncol Biol Phys. 2006;65:1416–21.

    Article  PubMed  Google Scholar 

  37. Mariani L, Salvadori B, Marubini E, Conti AR, Rovini D, Cusumano F, et al. Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer. Eur J Cancer. 1998;34:1156–62.

    Article  CAS  PubMed  Google Scholar 

  38. Fukamachi K, Ishida T, Usami S, Takeda M, Watanabe M, Sasano H, et al. Total-circumference intraoperative frozen section analysis reduces margin-positive rate in breast-conservation surgery. Jpn J Clin Oncol. 2010;40:513–20.

    Article  PubMed  Google Scholar 

  39. Kyndi M, Sorensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol. 2008;26:1419–26.

    Article  CAS  PubMed  Google Scholar 

  40. Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol. 2008;26:2373–8.

    Article  PubMed  Google Scholar 

  41. Solin LJ. Tailored local-regional treatment for early-stage breast cancer. Clin Breast Cancer. 2010;10:343–4.

    Article  PubMed  Google Scholar 

  42. Haffty BG, Vicini FA, Beitsch P, Quiet C, Keleher A, Garcia D, et al. Timing of chemotherapy after MammoSite radiation therapy system breast brachytherapy: analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Int J Radiat Oncol Biol Phys. 2008;72:1441–8.

    Article  PubMed  Google Scholar 

  43. Buchholz TA. Radiation therapy for early-stage breast cancer after breast-conserving surgery. N Engl J Med. 2009;360:63–70.

    Article  CAS  PubMed  Google Scholar 

  44. Rampinelli C, Bellomi M, Ivaldi GB, Intra M, Raimondi S, Meroni S, et al. Assessment of pulmonary fibrosis after radiotherapy (RT) in breast conserving surgery: comparison between conventional external beam RT (EBRT) and intraoperative RT with electrons (ELIOT). Technol Cancer Res Treat. 2011;10:323–9.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research was funded in part by the Japanese Foundation for Multidisciplinary Treatment of Cancer.

Conflict of interest

The authors state that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masataka Sawaki.

About this article

Cite this article

Sawaki, M., Kondo, N., Horio, A. et al. Feasibility of intraoperative radiation therapy for early breast cancer in Japan: a single-center pilot study and literature review. Breast Cancer 21, 415–422 (2014). https://doi.org/10.1007/s12282-012-0412-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-012-0412-8

Keywords

Navigation